FUZEON Side Effects

6955908-X | Application Site Discomfort, Application Site Erythema, Application Site Induration, Application Site Nodule, Application Site Pain, Weight Decreased, Weight Increased
on Aug 16, 2010 Female patient from BRAZIL , weighting 136.7 lb, was treated with Fuzeon (View Usage). Patient experienced the following unwanted or unexpected effects: application site discomfort, application site erythema, application site induration, application site nodule, application site pain, weight decreased, weight increased. Fuzeon dosage: Dose Reported As 90 Mg/ml. During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), DARUNAVIR ETHANOLATE (View Darunavir Ethanolate Review and Darunavir Ethanolate Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ISENTRESS (View Isentress Review and Isentress Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ).

6905828-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatic Enzyme Increased, Hepatic Steatosis, Hepatitis, Lymphadenopathy
Patient was taking Fuzeon (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic enzyme increased, hepatic steatosis, hepatitis (What is hepatitis?), lymphadenopathy on Jul 22, 2010 from CANADA Additional patient health information: Male patient , 46 years of age, weighting 207.2 lb, . Fuzeon dosage: Dosage Form: Powder For Solution. During the same period patient was treated with INTELENCE (View Intelence Review and Intelence Label ), ISENTRESS (View Isentress Review and Isentress Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), VIREAD (View Viread Review and Viread Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), COTRIM (View Cotrim Review and Cotrim Label ).

6887694-6 | Application Site Nodule, Application Site Pain, Weight Decreased, Weight Increased
Adverse event was reported on Jul 26, 2010 by a Female patient taking Fuzeon (View Usage) (Dosage: Dose Reported As 90 Mg/ml) . Location: BRAZIL , weighting 136.7 lb, After Fuzeon was administered, patient had the following side effects: application site nodule, application site pain, weight decreased, weight increased. During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ISENTRESS (View Isentress Review and Isentress Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ).

6840016-9 | Hypersensitivity
on Jul 02, 2010 Female patient from BRAZIL , weighting 130.1 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Fuzeon (View Usage). Patient experienced the following unwanted or unexpected effects: hypersensitivity. Fuzeon dosage: Frequency: One Dose Every 12 Hours.. During the same period patient was treated with KALETRA (View Kaletra Review and Kaletra Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ).


6783701-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatic Enzyme Increased, Hepatic Steatosis, Liver Disorder, Lymphadenopathy
on Jun 14, 2010 Male patient from CANADA , 46 years of age, was treated with Fuzeon (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic enzyme increased, hepatic steatosis, liver disorder, lymphadenopathy. Fuzeon dosage: Dosage Form Reported As Powder For Solution. During the same period patient was treated with INTELENCE (View Intelence Review and Intelence Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), VIREAD (View Viread Review and Viread Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), BACTRIM (View Bactrim Review and Bactrim Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ).

6783699-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatic Enzyme Increased, Hepatic Steatosis, Hepatitis, Lymphadenopathy
Patient was taking Fuzeon (View Usage). After Fuzeon was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic enzyme increased, hepatic steatosis, hepatitis (What is hepatitis?), lymphadenopathy on Jun 14, 2010 from CANADA Additional patient health information: Male patient , 46 years of age, . Fuzeon dosage: Form: Powder For Solution. During the same period patient was treated with INTELENCE (View Intelence Review and Intelence Label ), ISENTRESS (View Isentress Review and Isentress Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), VIREAD (View Viread Review and Viread Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ).

6783687-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatic Enzyme Increased, Hepatic Steatosis, Hepatitis, Lymphadenopathy
Adverse event was reported on Jun 14, 2010 by a Male patient taking Fuzeon (View Usage) (Dosage: Dosage Form: Powder For Solution) . Location: CANADA , 46 years of age, weighting 207.2 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic enzyme increased, hepatic steatosis, hepatitis (What is hepatitis?), lymphadenopathy. During the same period patient was treated with INTELENCE (View Intelence Review and Intelence Label ), ISENTRESS (View Isentress Review and Isentress Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), VIREAD (View Viread Review and Viread Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), COTRIM (View Cotrim Review and Cotrim Label ).

6781423-2 | Abdominal Hernia, Hypersensitivity
on May 11, 2010 Female patient from BRAZIL , weighting 130.1 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Fuzeon (View Usage). Patient had the following side effects: abdominal hernia, hypersensitivity. Fuzeon dosage: Frequency: One Dose Every 12 Hours.. During the same period patient was treated with KALETRA (View Kaletra Review and Kaletra Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ).

6686496-3 | Autoimmune Thyroiditis, Immune Reconstitution Syndrome
on Apr 06, 2010 Male patient from UNITED STATES , 16 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Fuzeon (View Usage). After Fuzeon was administered, patient had the following side effects: autoimmune thyroiditis, immune reconstitution syndrome. Fuzeon dosage: . During the same period patient was treated with ISENTRESS (View Isentress Review and Isentress Label ), EPIVIR (View Epivir Review and Epivir Label ), INTELENCE (View Intelence Review and Intelence Label ), PREZISTA (View Prezista Review and Prezista Label ), NORVIR (View Norvir Review and Norvir Label ).

6634368-2 | Injection Site Mass, Injection Site Reaction, Lipodystrophy Acquired
Patient was taking Fuzeon (View Usage). Patient experienced the following unwanted or unexpected effects: injection site mass, injection site reaction, lipodystrophy acquired on Mar 01, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 160.1 lb, . Fuzeon dosage: . During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), TRUVADA (View Truvada Review and Truvada Label ), ZIAGEN (View Ziagen Review and Ziagen Label ), NORVIR (View Norvir Review and Norvir Label ).

6615673-2 |
Adverse event was reported on Feb 26, 2010 by a Male patient taking Fuzeon (View Usage) (Dosage: ) . Location: VENEZUELA , weighting 114.6 lb, . During the same period patient was treated with KIVEXA (View Kivexa Review and Kivexa Label ), REYATAZ (View Reyataz Review and Reyataz Label ), NORVIR (View Norvir Review and Norvir Label ).

6570038-7 |
on Jan 21, 2010 Male patient from UNITED STATES , 48 years of age, was treated with Fuzeon (View Usage). . Fuzeon dosage: .

6546298-5 | Blood Pressure Increased, Diabetes Mellitus, Dyspepsia, Injection Site Reaction, Malaise, Nervousness, Viral Load Increased, Weight Decreased
on Jan 12, 2010 Male patient from BRAZIL , weighting 156.5 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Fuzeon (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, diabetes mellitus, dyspepsia, injection site reaction, malaise, nervousness, viral load increased, weight decreased. Fuzeon dosage: Dose: 90 Mg/ml. During the same period patient was treated with INVIRASE (View Invirase Review and Invirase Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), VIDEX (Strength: 300 Mg) (View Videx Review and Videx Label ). Patient was hospitalized.

6437270-4 | Blood Pressure Increased, Diabetes Mellitus, Dyspepsia, Injection Site Reaction, Malaise, Nervousness, Viral Load Increased
Patient was taking Fuzeon (View Usage). Patient had the following side effects: blood pressure increased, diabetes mellitus, dyspepsia, injection site reaction, malaise, nervousness, viral load increased on Oct 28, 2009 from BRAZIL Additional patient health information: Male patient , weighting 156.5 lb, was diagnosed with hiv infection (What is hiv infection?) and. Fuzeon dosage: Dose: 90 Mg/ml. During the same period patient was treated with INVIRASE (View Invirase Review and Invirase Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), VIDEX (Strength: 300 Mg) (View Videx Review and Videx Label ). Patient was hospitalized.

6411657-8 | Cd4 Lymphocytes Decreased, Pain, Platelet Count Decreased, Viral Load Increased
Adverse event was reported on Oct 14, 2009 by a Male patient taking Fuzeon (View Usage) (Dosage: Dose: 90 Mg/ Ml) . Location: BRAZIL , 53 years of age, weighting 156.1 lb, After Fuzeon was administered, patient had the following side effects: cd4 lymphocytes decreased, pain (What is pain?), platelet count decreased, viral load increased. During the same period patient was treated with RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ). Patient was hospitalized.

6373987-8 | Pain, Platelet Count Decreased
on Sep 14, 2009 Male patient from BRAZIL , 53 years of age, weighting 156.1 lb, was treated with Fuzeon (View Usage). Patient experienced the following unwanted or unexpected effects: pain (What is pain?), platelet count decreased. Fuzeon dosage: Dose: 90 Mg/ Ml. During the same period patient was treated with RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ). Patient was hospitalized.

6312315-0 | Adverse Event, Cd4 Lymphocytes Decreased, Central Nervous System Lesion, Progressive Multifocal Leukoencephalopathy, Quadriparesis, Therapeutic Response Decreased, Toxoplasmosis
on Aug 04, 2009 Male patient from BRAZIL , 33 years of age, was treated with Fuzeon (View Usage). Patient had the following side effects: adverse event, cd4 lymphocytes decreased, central nervous system lesion, progressive multifocal leukoencephalopathy, quadriparesis, therapeutic response decreased, toxoplasmosis. Fuzeon dosage: Other Indication:acquired Immuno Defficiency Syndrome, Route:subcutaneous,dose:90mg/ml. During the same period patient was treated with RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ). Patient was hospitalized and became disabled.

6265981-2 | Adverse Event, Cd4 Lymphocytes Decreased, Central Nervous System Lesion, Progressive Multifocal Leukoencephalopathy, Toxoplasmosis
Patient was taking Fuzeon (View Usage). After Fuzeon was administered, patient had the following side effects: adverse event, cd4 lymphocytes decreased, central nervous system lesion, progressive multifocal leukoencephalopathy, toxoplasmosis on Jul 06, 2009 from BRAZIL Additional patient health information: Male patient , 33 years of age, . Fuzeon dosage: . During the same period patient was treated with RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ). Patient was hospitalized and became disabled.

6257504-9 | Cyanosis, Syncope
Adverse event was reported on Jun 26, 2009 by a Female patient taking Fuzeon (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: ROMANIA , 32 years of age, Patient experienced the following unwanted or unexpected effects: cyanosis, syncope.

6251411-3 | Injection Site Erythema, Injection Site Induration, Injection Site Swelling, Osteonecrosis, Pain In Extremity
on Jun 23, 2009 Male patient from UNITED STATES , 48 years of age, was treated with Fuzeon (View Usage). Patient had the following side effects: injection site erythema, injection site induration, injection site swelling, osteonecrosis (What is osteonecrosis?), pain in extremity. Fuzeon dosage: .

6216088-1 | Muscular Weakness, Paraesthesia
on Jun 03, 2009 Male patient from IRELAND , 44 years of age, was treated with Fuzeon (View Usage). After Fuzeon was administered, patient had the following side effects: muscular weakness, paraesthesia. Fuzeon dosage: . During the same period patient was treated with DARUNAVIR (View Darunavir Review and Darunavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ).

6211795-9 | Body Temperature Increased, Knee Operation
Patient was taking Fuzeon (View Usage). Patient experienced the following unwanted or unexpected effects: body temperature increased, knee operation on May 21, 2009 from UNITED STATES Additional patient health information: Male patient , 46 years of age, . Fuzeon dosage: . Patient was hospitalized.

6191306-7 | Hepatitis, Porphyria
Adverse event was reported on Apr 30, 2009 by a Male patient taking Fuzeon (View Usage) (Dosage: ) . Location: BRAZIL , 54 years of age, Patient had the following side effects: hepatitis (What is hepatitis?), porphyria. During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), MARAVIROC (View Maraviroc Review and Maraviroc Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ). Patient was hospitalized.

6188088-1 | Injection Site Reaction
on Mar 03, 2009 Male patient from UNITED STATES , 16 years of age, was treated with Fuzeon (View Usage). After Fuzeon was administered, patient had the following side effects: injection site reaction. Fuzeon dosage: . Patient was hospitalized.

6188087-X | Injection Site Rash
on Jan 26, 2009 Female patient from UNITED STATES , 52 years of age, weighting 126.1 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with Fuzeon (View Usage). Patient experienced the following unwanted or unexpected effects: injection site rash. Fuzeon dosage: 90 Mg 2 Per Day Subcutaneous. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), ETRAVIRINE (ETRAVIRINE) (View Etravirine (etravirine) Review and Etravirine (etravirine) Label ), RALTEGRAVIR (RALTEGRAVIR) (View Raltegravir (raltegravir) Review and Raltegravir (raltegravir) Label ).

6188078-9 | Cd4 Lymphocytes Abnormal, Injection Site Induration, Injection Site Nodule
Patient was taking Fuzeon (View Usage). Patient had the following side effects: cd4 lymphocytes abnormal, injection site induration, injection site nodule on Apr 17, 2008 from UNITED STATES Additional patient health information: Male patient , 42 years of age, was diagnosed with acquired immunodeficiency syndrome and. Fuzeon dosage: 90 Mg 2 Per Day.

6169996-4 | Central Nervous System Lesion, Toxoplasmosis
Adverse event was reported on Apr 14, 2009 by a Male patient taking Fuzeon (View Usage) (Dosage: ) . Location: BRAZIL , 33 years of age, After Fuzeon was administered, patient had the following side effects: central nervous system lesion, toxoplasmosis. During the same period patient was treated with RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ). Patient was hospitalized.

6154160-5 | Diabetes Mellitus
on Apr 01, 2009 Male patient from UNITED STATES , weighting 207.2 lb, was diagnosed with hypertension, fibromyalgia and was treated with Fuzeon (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus. Fuzeon dosage: . During the same period patient was treated with RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), ETRAVIRINE (View Etravirine Review and Etravirine Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), AMITRIPTLINE HYDROCHLORIDE TAB (View Amitriptline Hydrochloride Tab Review and Amitriptline Hydrochloride Tab Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), NEXIUM (View Nexium Review and Nexium Label ), MEPRON (View Mepron Review and Mepron Label ).

6146152-7 | Amyloidosis, Injection Site Reaction
on Mar 23, 2009 Male patient from UNITED STATES , 47 years of age, was treated with Fuzeon (View Usage). Patient had the following side effects: amyloidosis, injection site reaction. Fuzeon dosage: .

6145989-8 | Diabetes Mellitus
Patient was taking Fuzeon (View Usage). After Fuzeon was administered, patient had the following side effects: diabetes mellitus on Mar 26, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 207.2 lb, was diagnosed with hypertension, fibromyalgia and. Fuzeon dosage: . During the same period patient was treated with RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), ETRAVIRINE (View Etravirine Review and Etravirine Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), NEXIUM (View Nexium Review and Nexium Label ), MEPRON (View Mepron Review and Mepron Label ).

6142972-3 | Amyloidosis, Injection Site Reaction
Adverse event was reported on Mar 25, 2009 by a Male patient taking Fuzeon (View Usage) (Dosage: ) . Location: UNITED STATES , 47 years of age, Patient experienced the following unwanted or unexpected effects: amyloidosis, injection site reaction.

6132271-8 | Cd4 Lymphocytes Decreased, Pneumocystis Jiroveci Pneumonia
on Mar 10, 2009 Female patient from BRAZIL , 45 years of age, was treated with Fuzeon (View Usage). Patient had the following side effects: cd4 lymphocytes decreased, pneumocystis jiroveci pneumonia. Fuzeon dosage: . During the same period patient was treated with DARUNAVIR (View Darunavir Review and Darunavir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ).

6128140-X | Type 1 Diabetes Mellitus
on Mar 12, 2009 Male patient from UNITED STATES , 50 years of age, was treated with Fuzeon (View Usage). After Fuzeon was administered, patient had the following side effects: type 1 diabetes mellitus. Fuzeon dosage: .

6127623-6 | Toxoplasmosis
Patient was taking Fuzeon (View Usage). Patient experienced the following unwanted or unexpected effects: toxoplasmosis on Mar 10, 2009 from BRAZIL Additional patient health information: Female patient , 33 years of age, . Fuzeon dosage: . During the same period patient was treated with RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ). Patient was hospitalized.

6120688-7 | Cd4 Lymphocytes Decreased, Pneumocystis Jiroveci Pneumonia
Adverse event was reported on Mar 10, 2009 by a Female patient taking Fuzeon (View Usage) (Dosage: ) . Location: BRAZIL , 45 years of age, Patient had the following side effects: cd4 lymphocytes decreased, pneumocystis jiroveci pneumonia. During the same period patient was treated with DARUNAVIR (View Darunavir Review and Darunavir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ).

6119223-9 | Infection, Oesophagitis, Viral Load Increased
on Mar 03, 2009 Male patient from UNITED STATES , 20 years of age, was treated with Fuzeon (View Usage). After Fuzeon was administered, patient had the following side effects: infection (What is infection?), oesophagitis, viral load increased. Fuzeon dosage: Patient Took Fuzeon 1-2 Years Ago.. Patient was hospitalized.

6085189-3 | Disease Progression, Injection Site Reaction
on Feb 10, 2009 Male patient from UNITED STATES , 49 years of age, was treated with Fuzeon (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression, injection site reaction. Fuzeon dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), BACTRIM DS (Dose Reported As 800 Od) (View Bactrim Ds Review and Bactrim Ds Label ), TRICOR (View Tricor Review and Tricor Label ), ETRAVIRINE (View Etravirine Review and Etravirine Label ).

6082439-4 | Hepatic Failure
Patient was taking Fuzeon (View Usage). Patient had the following side effects: hepatic failure on Feb 12, 2009 from UNITED STATES Additional patient health information: Male patient , 48 years of age, . Fuzeon dosage: Form: Vial.

6026546-0 | Hepatic Failure
Adverse event was reported on Dec 20, 2008 by a Male patient taking Fuzeon (View Usage) (Dosage: Form: Vial) . Location: UNITED STATES , 48 years of age, After Fuzeon was administered, patient had the following side effects: hepatic failure.

6026122-X | Arthropathy, Colorectal Cancer, Gastroenteritis Radiation, Injection Site Rash, Injection Site Reaction, Intestinal Obstruction, Neuropathy Peripheral, Short-bowel Syndrome
on Dec 22, 2008 Male patient from UNITED STATES , 70 years of age, was treated with Fuzeon (View Usage). Patient experienced the following unwanted or unexpected effects: arthropathy, colorectal cancer (What is colorectal cancer?), gastroenteritis radiation, injection site rash, injection site reaction, intestinal obstruction, neuropathy peripheral, short-bowel syndrome. Fuzeon dosage: . During the same period patient was treated with KALETRA (View Kaletra Review and Kaletra Label ), ZIAGEN (View Ziagen Review and Ziagen Label ), VIDEX (View Videx Review and Videx Label ), FLOMAX (View Flomax Review and Flomax Label ), VESICARE (View Vesicare Review and Vesicare Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), SOMA (View Soma Review and Soma Label ). Patient was hospitalized.

6026120-6 | Hepatic Failure
on Dec 24, 2008 Male patient from UNITED STATES , 48 years of age, was treated with Fuzeon (View Usage). Patient had the following side effects: hepatic failure. Fuzeon dosage: Form: Vial.

6020188-9 | Disease Progression
Patient was taking Fuzeon (View Usage). After Fuzeon was administered, patient had the following side effects: disease progression on Dec 15, 2008 from UNITED STATES Additional patient health information: Male patient , 49 years of age, . Fuzeon dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), BACTRIM DS (Dose Reported As 800 Od) (View Bactrim Ds Review and Bactrim Ds Label ), TRICOR (View Tricor Review and Tricor Label ), ETRAVIRINE (View Etravirine Review and Etravirine Label ).

6011616-3 | Myocardial Infarction
Adverse event was reported on Nov 06, 2007 by a Male patient taking Fuzeon (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 64 years of age, Patient experienced the following unwanted or unexpected effects: myocardial infarction. During the same period patient was treated with ISENTRESS (View Isentress Review and Isentress Label ), MARAVIROC (Trade Name Reported As 'selzentry'.) (View Maraviroc Review and Maraviroc Label ).

5858411-3 | Castleman's Disease, Febrile Neutropenia
on Aug 18, 2008 Male patient from UNITED STATES , 49 years of age, was diagnosed with hiv infection (What is hiv infection?), castleman's disease and was treated with Fuzeon (View Usage). Patient had the following side effects: castleman's disease, febrile neutropenia. Fuzeon dosage: Started As Part Of New Haart Regimen.. During the same period patient was treated with RITUXIMAB (6 Cycles. Given In Combination With Chop.) (View Rituximab Review and Rituximab Label ), VIREAD (Started As Part Of New Haart Regimen.) (View Viread Review and Viread Label ), EPIVIR (Started As Part Of New Haart Regimen.) (View Epivir Review and Epivir Label ), VIDEX (Started As Part Of New Haart Regimen.) (View Videx Review and Videx Label ), CYCLOPHOSPHAMIDE (Given Daily For Five Days Every 21 Days For 6 Cycles. Part Of Chop.) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (Given Daily For Five Days Every 21 Days For 6 Cycles. Part Of Chop.) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (Maximum Daily Dose Of 2mg. Given Daily For Five Days Every 21 Days For 6 Cycles. Part Of Chop.) (View Vincristine Review and Vincristine Label ).

5857315-X | Adrenal Insufficiency, Blood Alkaline Phosphatase Increased, Clostridium Difficile Colitis, Dehydration, Headache, Hypotension, Liver Function Test Abnormal, Nausea, Pyrexia
on Aug 12, 2008 Male patient from UNITED STATES , 43 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Fuzeon (View Usage). After Fuzeon was administered, patient had the following side effects: adrenal insufficiency, blood alkaline phosphatase increased, clostridium difficile colitis, dehydration, headache (What is headache?), hypotension, liver function test abnormal, nausea (What is nausea?), pyrexia. Fuzeon dosage: . During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), KALETRA (View Kaletra Review and Kaletra Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), MK 0518 (View Mk-0518 Review and Mk-0518 Label ), TRUVADA (View Truvada Review and Truvada Label ), COMBIVIR (View Combivir Review and Combivir Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), DAPSONE (View Dapsone Review and Dapsone Label ). Patient was hospitalized.

5794951-3 | Blood Cholesterol Increased, Blood Triglycerides Increased, Injection Site Erythema, Injection Site Haematoma, Injection Site Nodule, Injection Site Pain, Injection Site Pruritus, Injection Site Swelling
Patient was taking Fuzeon (View Usage). Patient experienced the following unwanted or unexpected effects: blood cholesterol increased, blood triglycerides increased, injection site erythema, injection site haematoma, injection site nodule, injection site pain, injection site pruritus, injection site swelling on Jun 17, 2008 from BRAZIL Additional patient health information: Male patient , weighting 180.8 lb, was diagnosed with hiv infection (What is hiv infection?), pain (What is pain?), prophylaxis and. Fuzeon dosage: Dosage Regimen Reported As: 2 Times A Day. During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), KALETRA (View Kaletra Review and Kaletra Label ), VIREAD (View Viread Review and Viread Label ), STOCRIN (View Stocrin Review and Stocrin Label ), BACTRIM (View Bactrim Review and Bactrim Label ).

5787532-9 | Abortion Spontaneous, Placental Infarction, Umbilical Cord Abnormality
Adverse event was reported on Jun 17, 2008 by a Female patient taking Fuzeon (View Usage) (Dosage: ) was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and. Location: UNITED KINGDOM , weighting 133.4 lb, Patient had the following side effects: abortion spontaneous, placental infarction, umbilical cord abnormality. During the same period patient was treated with VALGANCICLOVIR HCL (View Valganciclovir Hcl Review and Valganciclovir Hcl Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), REYATAZ (View Reyataz Review and Reyataz Label ), NORVIR (View Norvir Review and Norvir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), COTRIM (View Cotrim Review and Cotrim Label ).

5766534-2 | Contusion, Haemarthrosis, Haematoma, Haemorrhagic Diathesis, Soft Tissue Haemorrhage
on May 30, 2008 Male patient from UNITED KINGDOM , 27 years of age, was treated with Fuzeon (View Usage). After Fuzeon was administered, patient had the following side effects: contusion, haemarthrosis, haematoma, haemorrhagic diathesis, soft tissue haemorrhage. Fuzeon dosage: . During the same period patient was treated with TIPRANAVIR (View Tipranavir Review and Tipranavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

5756707-7 | Injection Site Erythema, Injection Site Induration, Injection Site Pain, Injection Site Pruritus, Myalgia, Paraesthesia
on May 28, 2008 Male patient from UNITED STATES , weighting 149.9 lb, was treated with Fuzeon (View Usage). Patient experienced the following unwanted or unexpected effects: injection site erythema, injection site induration, injection site pain, injection site pruritus, myalgia, paraesthesia. Fuzeon dosage: . During the same period patient was treated with DARUNAVIR (View Darunavir Review and Darunavir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ).

5747502-3 | Disease Progression
Patient was taking Fuzeon (View Usage). Patient had the following side effects: disease progression on May 12, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 87.08 lb, . Fuzeon dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ).